News >

Expert Sheds Light on Rapid Progress in Relapsed/Refractory Myeloma

Caroline Seymour
Published: Tuesday, Oct 08, 2019

Ivan M. Borrello, MD

Ivan M. Borrello, MD

Given the number of treatment regimens that have become available to patients with relapsed/refractory multiple myeloma, the decision of which strategy to pursue should be grounded in the nature of the relapse, the setting in which it occurs, and any comorbidities that may present contraindications to specific agents, explained Ivan M. Borrello, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Medical Crossfire®: How Can We Optimize Outcomes in Head and Neck Cancers with Immunotherapeutic Strategies?Oct 31, 20191.5
The Patient and Provider Connection™: Effective Communication to Optimize the Diagnosis and Management of Irritable Bowel Syndrome and Chronic Idiopathic ConstipationOct 31, 20191.0
Publication Bottom Border
Border Publication
x